Pingping Bi

机构：Kunming Medical University, The People's Hospital of LinXia

发表论文 4 篇 · 总被引 121 次 · h-index 3

代表论文

• Single‐cell transcriptome sequencing of B‐cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy (2023 · Clinical and Translational Medicine · 被引 102)
• Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer (2024 · APOPTOSIS · 被引 10)
• Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study (2023 · Surgery Open Science · 被引 6)
• Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer (2024 · Cancer Cell International · 被引 3)